EXPAREL

This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Lithuania, Poland, United States

Active ingredients

The drug EXPAREL contains one active pharmaceutical ingredient (API):

1 Bupivacaine UNII Y8335394RO - BUPIVACAINE

Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation. Read about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EXPAREL Suspension for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01BB01	Bupivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1833634, 1833645, 1833656, 1833667, 1833724, 1833735, 1833746, 1833757
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 100452, 518135
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091406, 1091407, 1091408, 1091409
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100445874, 100445880
Country: US	FDA, National Drug Code	Identifier(s): 65250-133, 65250-266